The Chinese government unveiled a program to woo foreign talent just as the US cracked down on H-1Bs with a $100,000 fee. The ...
Indian students face challenges studying abroad due to Trump administration policies, but U.S. universities still offer ...
A landmark study in China covering 42,703 families affected by rare diseases across 32 provincial regions of China has established a new diagnosis framework for rare diseases. It offers new hope to ...
Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that clinical data from Stage A of a Phase 3 study in China sponsored ...
A new analysis found that nearly 700 drugs approved for use in the United States depend on chemicals solely produced in China ...